bromodeoxyuridine has been researched along with Huntington Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guthrie, KM; Leon, RT; McCollum, MH; Rush, DB; Wei, J | 1 |
| de Castro Batista, CM; de Moraes Mello, LE; Mendez-Otero, R; Moraes, L; Shimabukuro, MK | 1 |
| Aigner, L; Bogdahn, U; Couillard-Despres, S; Kandasamy, M; Kohl, Z; Lehner, B; Nguyen, HP; Raber, KA; Riess, O; Rivera, FJ; Stephan, M; von Hörsten, S; Winkler, J; Winner, B | 1 |
| Barker, RA; Decressac, M; Gaillard, A; Tyers, P; Wright, B | 1 |
| Aigner, L; Aigner, R; Kandasamy, M; Kohl, Z; Regensburger, M; Winkler, J; Winner, B | 1 |
| Armstrong, RJ; Barker, RA; Blakemore, C; Grote, H; Hannan, AJ; Lazic, SE; van Dellen, A | 1 |
| Connor, B; Croon, RJ; Faull, RL; Kells, AP; Liu, YW; Tattersfield, AS | 1 |
| Araújo, IM; Brundin, P; Gil, JM; Li, JY; Mohapel, P; Petersén, A; Popovic, N | 1 |
| Chen, S; Crippen, D; Ellerby, LM; Gafni, J; Greenberg, DA; Jin, K; LaFevre-Bernt, M; Logvinova, A; Ross, CA; Sun, Y | 1 |
| Chen, K; Connor, B; Hughes, SM; Vazey, EM | 1 |
| Duan, W; Jiang, M; Li, Q; Masuda, N; Peng, Q; Ross, CA; Zhao, M | 1 |
| Bloxham, C; Crow, TJ; Davies, H; Parry, R; Tyrrell, DA | 1 |
| Beverstock, GC; Mol, A; Wienhofer, E | 1 |
13 other study(ies) available for bromodeoxyuridine and Huntington Disease
| Article | Year |
|---|---|
Striatal oligodendrogliogenesis and neuroblast recruitment are increased in the R6/2 mouse model of Huntington's disease.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Proliferation; Cerebral Ventricles; Corpus Striatum; Disease Models, Animal; Gene Expression Regulation; Huntington Disease; Mice; Mice, Mutant Strains; Neoplastic Stem Cells; Nerve Tissue Proteins; Neural Stem Cells; Oligodendrocyte Transcription Factor 2; Oligodendroglia; Time Factors | 2013 |
Lack of association between PSA-NCAM expression and migration in the rostral migratory stream of a Huntington's disease transgenic mouse model.
Topics: Animals; Apoptosis; Brain; Bromodeoxyuridine; Cell Movement; Disease Models, Animal; Female; Fluoresceins; Gene Expression; Huntingtin Protein; Huntington Disease; Immunohistochemistry; Male; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neural Cell Adhesion Molecule L1; Neurogenesis; Neurons; Nuclear Proteins; Sialic Acids | 2009 |
Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-beta signaling in an animal model of Huntington disease.
Topics: Age Factors; Animals; Animals, Genetically Modified; Bromodeoxyuridine; Cell Proliferation; CREB-Binding Protein; Disease Models, Animal; Doublecortin Domain Proteins; Gene Expression Regulation; Hippocampus; Huntingtin Protein; Huntington Disease; Male; Microtubule-Associated Proteins; Models, Biological; Nerve Tissue Proteins; Neurogenesis; Neuropeptides; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Rats; Signal Transduction; Smad2 Protein; SOXB1 Transcription Factors; Stem Cell Niche; Transforming Growth Factor beta; Trinucleotide Repeat Expansion | 2010 |
Neuropeptide Y modifies the disease course in the R6/2 transgenic model of Huntington's disease.
Topics: Animals; Antimetabolites; Behavior, Animal; Body Weight; Bromodeoxyuridine; Cell Count; Cell Proliferation; Disease Progression; Female; Hippocampus; Humans; Huntington Disease; Immunohistochemistry; Injections, Intraventricular; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neostriatum; Neuropeptide Y; Postural Balance; Stereotaxic Techniques; Survival Analysis | 2010 |
Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's disease.
Topics: Animals; Antimetabolites; Apoptosis; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Proliferation; Cell Survival; Corpus Striatum; Female; Huntingtin Protein; Huntington Disease; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mutation; Nerve Tissue Proteins; Neurogenesis; Neurons; Nuclear Proteins; Olfactory Bulb | 2010 |
Decreased hippocampal cell proliferation in R6/1 Huntington's mice.
Topics: Age Factors; Animals; Behavior, Animal; Bromodeoxyuridine; Cell Count; Cell Division; Disease Models, Animal; Hippocampus; Humans; Huntingtin Protein; Huntington Disease; Immunohistochemistry; Mice; Mice, Inbred CBA; Mice, Transgenic; Motor Activity; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Phosphopyruvate Hydratase; Time Factors | 2004 |
Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Topics: Animals; Biomarkers; Bromodeoxyuridine; Cell Death; Cell Differentiation; Cell Division; Cell Movement; Corpus Striatum; Denervation; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; gamma-Aminobutyric Acid; Huntington Disease; Immunohistochemistry; Male; Microtubule-Associated Proteins; Nerve Regeneration; Neurons; Neuropeptides; Neurotoxins; Quinolinic Acid; Rats; Rats, Wistar; Reaction Time; Stem Cells; Up-Regulation | 2004 |
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
Topics: Animals; Animals, Newborn; Biomarkers; Bromodeoxyuridine; Cell Division; Cell Proliferation; Disease Models, Animal; DNA-Binding Proteins; Doublecortin Domain Proteins; Down-Regulation; Female; Hippocampus; Humans; Huntingtin Protein; Huntington Disease; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neuronal Plasticity; Neurons; Neuropeptides; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Stem Cells | 2005 |
FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease.
Topics: Analysis of Variance; Animals; Blotting, Western; Bromodeoxyuridine; Cell Death; Cell Differentiation; Dopamine and cAMP-Regulated Phosphoprotein 32; Fibroblast Growth Factor 2; Humans; Huntington Disease; Immunohistochemistry; Mice; Mice, Transgenic; Multipotent Stem Cells; Neurons | 2005 |
Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
Topics: Analysis of Variance; Animals; Apomorphine; Brain Tissue Transplantation; Bromodeoxyuridine; Cell Count; Cell Differentiation; Disease Models, Animal; Dopamine Agonists; Huntington Disease; Immunohistochemistry; Male; Motor Activity; Neostriatum; Nerve Tissue Proteins; Neurons; Quinolinic Acid; Rats; Rats, Wistar; Stem Cell Transplantation; Time Factors; Transcription Factors; Tyrosine 3-Monooxygenase | 2006 |
The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model.
Topics: Age Factors; Animals; Antidepressive Agents; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Proliferation; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Huntington Disease; Male; Mice; Mice, Transgenic; Motor Activity; Nerve Tissue Proteins; Neurons; Phenotype; Sertraline | 2008 |
Further studies of the cytopathic effect in tissue cultures inoculated with CSF from patients with schizophrenia and other nervous system diseases.
Topics: Adult; Bromodeoxyuridine; Cells, Cultured; Cytopathogenic Effect, Viral; Fibroblasts; Humans; Huntington Disease; Microscopy, Electron; Middle Aged; Mycoplasma; Schizophrenia | 1983 |
Absence of significant autosomal lesions in Huntington's disease.
Topics: Adolescent; Adult; Aged; Bromodeoxyuridine; Cells, Cultured; Chromosome Fragile Sites; Chromosome Fragility; Culture Media; Female; Floxuridine; Humans; Huntington Disease; Male; Middle Aged; Translocation, Genetic | 1985 |